The rain in Peshawar does not merely fall; it lingers, heavy with the dust of the Khyber Pass and the scent of wet stone. For most, it is just weather. For Tariq, sitting by a narrow window in a house that smells faintly of cardamom and old lime plaster, the rain is an adversary. It is the cold creeping into his knuckles, the sudden, traitorous betrayal of his right leg, and the quiet tightening of a band around his chest that makes every breath feel like a negotiation.
Tariq has multiple sclerosis. But calling it multiple sclerosis in the neighborhoods outside the capital feels almost abstract, like naming a star you can never touch. Here, it is simply the thing that stole his walk, the thing that turned a vibrant schoolteacher into a man who counts the floorboards between his bed and the kettle.
Medicine exists for Tariq. That is the cruelest part of the arithmetic. Across the globe, neurologists prescribe disease-modifying therapies that can slow the march of the disease, keeping nerve fibers wrapped in their protective myelin, keeping futures intact. Yet between Tariq and those vials of liquid promise stands an invisible wall built of broken policy, prohibitive costs, and bureaucratic indifference.
Consider the geography of exclusion. Khyber Pakhtunkhwa is a province of jagged peaks, proud traditions, and deep-rooted resilience. It is also a healthcare desert for chronic, invisible neurological conditions. When the federal health machinery turns its gaze toward the periphery, certain ailments simply fall off the ledger. Cancer gets campaigns. Infectious diseases get emergency funding. But a degenerative condition that slowly frays the central nervous system? That is treated as an individual misfortune rather than a collective failure.
The math is brutal. A single month of proper treatment can cost more than a family's annual income. Imagine standing in a pharmacy, holding a prescription that could save your mobility, while the pharmacist shakes his head not out of cruelty, but because the import taxes alone have pushed the price into the realm of the impossible. You walk home. You leave the paper on the table. You wait for the next numbness to creep past your knee.
Policy gaps are not just lines on a government report. They are empty chairs at dinner tables. They are the silence in a room where a breadwinner used to laugh.
When we talk about health crises in Pakistan, our minds often drift to overcrowded emergency rooms in Lahore or Karachi, to the dramatic flashes of cholera outbreaks or Dengue spikes. Those crises demand headlines. They have an urgent, bleeding visibility. Multiple sclerosis bleeds quietly. It wears down the caregiver, usually a wife or a daughter, whose own health fractures under the strain of lifting deadweight limbs and managing unpredictable spasms without a single day of respite or institutional support.
Tariq remembers the day of his diagnosis with startling clarity. The neurologist had been clinical, almost apologetic, handing over an MRI scan that looked like a night sky peppered with dark, ominous constellations. Those spots were lesions—scars where the immune system had mistaken the body's own wiring for an enemy combatant.
"Can it be treated?" Tariq had asked, his voice steady only because shock acts as an anesthetic.
"Yes," the doctor said. "The medications are available. In Islamabad. In Karachi. Sometimes."
Sometimes. That was the anchor dropped squarely on his chest.
In Khyber Pakhtunkhwa, specialized neurology care is concentrated in a handful of tertiary hospitals in Peshawar, leaving millions of rural citizens stranded hours away from a magnetic resonance machine or an expert consultation. A patient from Swat or Dir must travel treacherous mountain roads just to confirm a relapse, enduring physical jolts that worsen their symptoms before they even reach the clinic door. Once there, they encounter subsidized drug programs that are chronically underfunded, leaving formularies perpetually empty. The bureaucratic gears grind slowly, but the disease does not wait for committee approvals.
There is a profound psychological toll to living in a blind spot. It breeds a unique brand of isolation. Friends stop calling because they do not know what to say to someone whose body is slowly forgetting how to cooperate. Employers offer sympathy wrapped in dismissal, quietly easing the sick worker out the door to make room for someone dependable. The financial collapse follows the physical one with the merciless precision of a falling domino. Savings vanish into private consultations and unapproved generic imports of dubious efficacy.
Yet, beneath the weight of this neglect, human dignity refuses to surrender entirely.
In a small courtyard in Peshawar, families gather not to mourn what is lost, but to share the heavy burden of survival. They trade tips on where to source cheaper medications smuggled across borders. They lend wheelchairs. They sit in the afternoon sun and talk about the days before the numbness set in, reclaiming their past because the present is too steep a hill to climb alone.
Change will not arrive because of a sudden awakening in the corridors of power. Systems do not care until they are forced to care. The treatment gap in Khyber Pakhtunkhwa will only close when patients and their families stop whispering about their symptoms in the dark and begin demanding that healthcare be treated not as a privilege for the postal codes that can afford it, but as a fundamental right of citizenship.
Until that day arrives, Tariq sits by his window, watching the rain carve silver tracks down the glass, waiting for a policy shift that moves at the speed of a dying nerve.
